ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

Consensus conference On Cervical Cancer

January 26, 1996

Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data

July 30, 2010

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004